Last10K.com

American Brivision (ABVC) SEC Filing 10-K Annual report for the fiscal year ending Saturday, September 30, 2017

American Brivision

HISTORY TOOLS
CIK: 1173313 Ticker: ABVC
Document and Entity Information - USD ($)
12 Months Ended
Sep. 30, 2017
Mar. 31, 2017
Jan. 11, 2017
Document and Entity Information [Abstract]   
Entity Registrant NameAmerican BriVision (Holding) Corp  
Entity Central Index Key0001173313  
Trading SymbolMTOO  
Amendment Flagfalse  
Current Fiscal Year End Date--09-30  
Document Type10-K  
Document Period End DateSep. 30, 2017  
Document Fiscal Year Focus2017  
Document Fiscal Period FocusFY  
Entity Well-known Seasoned IssuerNo  
Entity Voluntary FilersNo  
Entity Current Reporting StatusYes  
Entity Filer CategorySmaller Reporting Company  
Entity Public Float $ 69,924,306 
Entity Common Stock, Shares Outstanding  213,746,647

View differences made from one year to another to evaluate American Brivision's financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 10-K Annual Report to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by American Brivision.

Continue

Assess how American Brivision's management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

American Brivision's Definitive Proxy Statement (Form DEF 14A) filed after their 2018 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors

Continue

SEC Filing Tools

Financial Statements, Disclosures and Schedules

Inside this 10-K Annual Report

Document And Entity Information
Consolidated Balance Sheets
Consolidated Balance Sheets (parenthetical)
Consolidated Statements Of Cash Flows
Consolidated Statements Of Operations
Consolidated Statements Of Stockholders??? Equity (deficit)
Accrued Expenses
Accrued Expenses (details)
Accrued Expenses (tables)
Collaborative Agreements
Collaborative Agreements (details)
Commitments And Contingencies
Commitments And Contingencies (details Textual)
Commitments And Contingencies (details)
Commitments And Contingencies (tables)
Corrections To Previously Issued Consolidated Financial Statements
Corrections To Previously Issued Consolidated Financial Statements (details Textual)
Corrections To Previously Issued Consolidated Financial Statements (details)
Corrections To Previously Issued Consolidated Financial Statements (tables)
Equity
Equity (details)
Going Concern
Going Concern (details)
Income Tax
Income Tax (details 1)
Income Tax (details 2)
Income Tax (details)
Income Tax (tables)
Loss Per Share
Loss Per Share (details)
Loss Per Share (tables)
Organization And Description Of Business
Organization And Description Of Business (details)
Related Parties Transactions
Related Parties Transactions (details 1)
Related Parties Transactions (details Textual)
Related Parties Transactions (details)
Related Parties Transactions (tables)
Subsequent Event
Summary Of Significant Accounting Policies
Summary Of Significant Accounting Policies (details)
Summary Of Significant Accounting Policies (policies)

Material Contracts, Statements, Certifications & more

American Brivision provided additional information to their SEC Filing as exhibits

Exhibit 31.1: Certification
Exhibit 31.2: Certification
Exhibit 32.1: Certification
Exhibit 32.2: Certification
Ticker: ABVC
CIK: 1173313
Form Type: 10-K Annual Report
Accession Number: 0001213900-18-000537
Submitted to the SEC: Tue Jan 16 2018 2:57:28 PM EST
Accepted by the SEC: Tue Jan 16 2018
Period: Saturday, September 30, 2017
Industry: Pharmaceutical Preparations

External Resources:
Stock Quote
Social Media
SEC.gov

Bookmark the Permalink:
https://last10k.com/sec-filings/abvc/0001213900-18-000537.htm